Innate Pharma S.A. - American Depositary Shares (IPHA) SEC filings
IPHA SEC filings moved a median of -1.57% by the close. IPHA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the IPHA overview →
16 measured IPHA SEC filing events.
Where these IPHA SEC filings landedvs 15 measured IPHA SEC filing reactions
| Middle 50% of IPHA SEC filing reactions | -4.02% to +0.23% |
|---|---|
| Median reaction (to close) | -1.57% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 IPHA SEC filing events with a measured close landed between -4.02% and +0.23%; 27% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 6-K Innate Pharma SA For: Jun 30 | SEC filing · Form 6-K | -1.60% | -4.02% | |
| Form 6-K Innate Pharma SA For: Sep 16 | SEC filing · Form 6-K | -1.60% | -4.02% | |
| Form 6-K Innate Pharma SA For: Sep 17 | SEC filing · Form 6-K | -1.60% | -4.02% | |
| Form 6-K Innate Pharma SA For: Sep 10 | SEC filing · Form 6-K | -0.52% | -1.57% | |
| Form 6-K Innate Pharma SA For: Sep 02 | SEC filing · Form 6-K | — | +0.46% | |
| Form 6-K Innate Pharma SA For: Aug 19 | SEC filing · Form 6-K | +0.94% | -2.34% | |
| Form 6-K Innate Pharma SA For: Aug 14 | SEC filing · Form 6-K | -1.83% | +0.00% | |
| Form 6-K Innate Pharma SA For: Aug 10 | SEC filing · Form 6-K | +0.42% | — | |
| Form 6-K Innate Pharma SA For: Jul 23 | SEC filing · Form 6-K | -0.56% | -0.56% | |
| Form 6-K Innate Pharma SA For: Jul 21 | SEC filing · Form 6-K | — | -0.28% | |
| Form 6-K Innate Pharma SA For: May 22 | SEC filing · Form 6-K | +1.06% | -3.17% | |
| Form 6-K Innate Pharma SA For: May 19 | SEC filing · Form 6-K | -3.18% | -7.73% | |
| Form 6-K Innate Pharma SA For: May 13 | SEC filing · Form 6-K | +0.00% | -6.38% | |
| Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual Report | Press release | +0.00% | +1.48% | |
| Innate Pharma Files Its 2024 Universal Registration Document (Document d’enregistrement universel) and 2024 Annual Report on Form 20-F | Press release | — | +1.36% | |
| Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F | Press release | +0.00% | +1.71% |
Keep exploring
More IPHA: earnings → · analyst actions → · IPHA overview →